Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 5;15(1):4323.
doi: 10.1038/s41598-025-86488-9.

Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study

Affiliations

Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study

Behnam Ermian et al. Sci Rep. .

Abstract

Nephrotic syndrome, the most common glomerular disease in pediatric population, is classified into two groups of steroid sensitive (SSNS) and resistant (SSRS). There is growing evidence on the role of T cells cytokines, including interleukin-13, in pathophysiology of nephrotic syndrome and steroid response. This study was a cross-sectional study conducted at Children's Medical Center Hospital in order to explore the relationship between urinary IL-13 levels and responsiveness to corticosteroid treatment. All children (1 to 15 years) referred from January 2021 to January 2022 diagnosed with nephrotic syndrome were included. Urine samples were collected during the initial phase or relapse of nephrotic syndrome, before the initiation of steroid or alternative treatments. Interleukin-13 levels in the urine were measured using the ELISA method. In this study, 83 cases of nephrotic syndrome were enrolled, of whom 30 (36.1%) were girls and 53 (63.9%) were boys. Out of the 83 cases, 63 (75.9%) were identified as SSNS and 20 (24.1%) as SRNS. There was no significant difference between the urinary interleukin-13 levels between SSNS and SRNS groups (P-value: 0.84). Sex (P-value: 0.598) and age (P-value: 0.704) also had no association with interleukin-13 levels. Further studies in larger population are recommended to better assess the potential of this biomarker to predict response to treatment. .

Keywords: Child; Idiopathic; Nephrotic syndrome; Steroid-resistant; Steroids.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethical approval: Informed consent was obtained from all participants. Ethical approval for this study was obtained from the Ethics Committee of Tehran University of Medical Sciences, allowing access to and extraction of patient data from hospital files and records (Batch Number: IR.TUMS.CHMC.REC.1401.188). All methods of project were carried out in accordance with and the manuscript has been written aligned with STROBE checklist for observational studies.

Similar articles

References

    1. Rodriguez-Ballestas, E. & Reid-Adam, J. Nephrotic syndrome. Pediatr. Rev.43(2), 87–99 (2022). - PubMed
    1. Vivarelli, M., Gibson, K., Sinha, A. & Boyer, O. Childhood nephrotic syndrome. Lancet402(10404), 809–824 (2023). - PubMed
    1. Zotta, F., Vivarelli, M. & Emma, F. Update on the treatment of steroid-sensitive nephrotic syndrome. Pediatr. Nephrol.37(2), 303–314 (2022). - PubMed
    1. Hodson, E. M., Hahn, D., Alexander, S. I., Graf, N. & McCarthy, H. Steroid Sensitive Nephrotic Syndrome, 405–442 (Springer, 2023).
    1. Cara-Fuentes, G. & Smoyer, W. E. Biomarkers in pediatric glomerulonephritis and nephrotic syndrome. Pediatr. Nephrol.36(9), 2659–2673 (2021). - PubMed

LinkOut - more resources